Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Hughes, Caryn and Clemens, Graeme and Baker, Matthew J. (2015) Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy. Trends in Biotechnology, 33 (8). pp. 429-430. ISSN 0167-7799

[thumbnail of Hughes-etal-TIB-2015-Preclinical-screening-of-anticancer-drugs-using-infrared]

Preview

Text (Hughes-etal-TIB-2015-Preclinical-screening-of-anticancer-drugs-using-infrared)
Hughes_etal_TIB_2015_Preclinical_screening_of_anticancer_drugs_using_infrared.pdf
Accepted Author Manuscript
License:

Download (477kB)| Preview

Official URL: https://doi.org/10.1016/j.tibtech.2015.03.010

Abstract

High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

ORCID iDs

Hughes, Caryn, Clemens, Graeme and Baker, Matthew J.

;

Citations and altmetrics

Item metadata

Item type:	Article
ID code:	55821
Dates:	Date Event 17 July 2015 Published 10 April 2015 Published Online 1 April 2015 Accepted
Keywords:	cancer, infrared, spectroscopy, high throughput, preclinical screening, biomarker, Pharmacy and materia medica, Chemistry, Neoplasms. Tumors. Oncology (including Cancer), Chemistry(all)
Subjects:	Medicine > Pharmacy and materia medica Science > Chemistry Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Department:	Faculty of Science > Pure and Applied Chemistry
Depositing user:	Pure Administrator
Date deposited:	09 Mar 2016 16:23
Last modified:	30 Mar 2021 00:41
Related URLs:	Scopus publication
URI:	https://strathprints.strath.ac.uk/id/eprint/55821

Export

CORE (COnnecting REpositories)